Implementation of a self-administered questionnaire to identify patients at risk for medication-related problems in a family health center

Pharmacotherapy

Volumn 26, Issue 2, 2006, Pages 260-268

  Langford, Bradley J ^a   Jorgenson, Derek ^b   Kwan, Debora ^a   Papoushek, Christine ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b SASKATOON HEALTH REGION   (Canada)

Author keywords

Medication related problem; MRP; Pharmacist referral; Pharmacist review; Screening tool; Self administered questionnaire

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG INDICATION; DRUG INTERACTION; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MEDICATION RELATED PROBLEM; PATIENT COMPLIANCE; PATIENT IDENTIFICATION; PATIENT REFERRAL; PHARMACIST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

AGED; AMBULATORY CARE FACILITIES; DATA INTERPRETATION, STATISTICAL; FAMILY HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RISK ASSESSMENT;

EID: 32044473298     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.2.260     Document Type: Article

References (16)

1. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
2. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003;289(9):1107-16.
3. Baker GR, Norton PG, Flintoft V. The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada. Can Med Assoc J 2004;170:1678-86.
4. Armour CL, Taylor SJ, Hourihan F, Smith C, Krass I. Implementation and evaluation of Australian pharmacists' diabetes care services. J Am Pharm Assoc 2004;44(4):455-66.
5. Carter BL, Malone DC, Billups SJ, et al. Interpreting findings of the IMPROVE study. Am J Health-Syst Pharm 2001;58(14)1330-7.
6. Tsuyuki RT, Johnson JA, Teo KK, Ackman ML, Taylor JG. Study of cardiovascular risk intervention by pharmacists. Ann Pharmacother 1999;33:910-19.
7. Ali F, Laurin MY, Lariviere C, Tremblay D, Cloutier D. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol 2003;10(3):101-6.
8. Jameson J, VanNoord G, Vanderwoud K. The impact of a pharmacotherapy consultation on the cost and outcome of medical therapy. J Fam Pract 1995;41:469-72.
9. McMullin ST, Hennenfent JA, Ritchie DJ, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999;159:2306-9.
10. Koecheler JA, Abramowitz PW, Swim SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989;46:729-32.
11. Barenholtz Levy H. Self-administered medication risk questionnaire in an elderly population. Ann Pharmacother 2003;37:982-7.
12. Isaksen SF, Jonassen J, Malone DC, Billups SJ, Carter BL, Sintek CD. Estimating risk factors for patients with potential drug-related problems using electronic pharmacy data. Ann Pharmacother 1999;33:406-12.
13. Blunt T, Deschamps M, Taylor J. Evaluating "just checking" as a practice tool for community pharmacists. Can Pharm J 2002;35(1)31-7.
14. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly, an update. Arch Intern Med 1997;157:1531-6.
15. Sellers J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. Can Med Assoc J 2003;169:17-22.
16. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older patents in the ambulatory setting. J Am Ger Soc 2004;52(8):1349-54.